SCHEMBL30890741

SCHEMBL30890741

CCCCOC(=O)N1C[C@@]2(C[C@H]1C(N)=O)Oc1c(cccc1-c1ccccc1)NC2=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 3/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HTT P42858 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ GRK2 P25098 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ OPRM1 P35372 1/20 0.32
▸ OPRD1 P41143 1/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ MAPK1 P28482 2/20 0.31
▸ POLB P06746 2/20 0.31
▸ APAF1 O14727 1/20 0.31
▸ APEX1 P27695 1/20 0.31
▸ CACNA1B Q00975 1/20 0.31
▸ APBA1 Q02410 1/20 0.31
▸ CTDSP1 Q9GZU7 1/20 0.31
▸ APOBEC3G Q9HC16 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ GYS1 P13807 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890474 0.87 TSHR (0.32) RECQLTSHRGRK2
SCHEMBL30890412 0.85 HSD17B10 (0.36) RECQLCYP3A4CYP2C19TSHRMAPT
SCHEMBL30992272 0.85 NR1H2 (0.43) —
SCHEMBL30890510 0.81 OTUD7B (0.40) RECQLCYP3A4CYP2C19TSHRGRK2
SCHEMBL30890404 0.79 POLB (0.36) TSHRMAPTMAPK1POLBTDP1
SCHEMBL30890444 0.79 POLB (0.36) TSHRMAPTMAPK1POLBTDP1
SCHEMBL30890780 0.77 MAOB (0.34) TSHRMAPT
SCHEMBL30890571 0.77 MAPT (0.34) MAPT
SCHEMBL30890576 0.75 OTUD7B (0.41) TSHRMAPTOPRD1OPRK1MAPK1
SCHEMBL30890640 0.74 ATM (0.36) RECQLCYP3A4CYP2C19HTTGRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback